Abstract
Systemic autoimmune diseases are disorders in which a variety of genetic and environmental factors interact to result in a loss of tolerance to self antigens and emergence of pathogenic autoantibodies. Multiple genes contribute to the development of these diseases, modulated by hormonal, environmental and infectious factors. Determining these interactions and their consequences is a fundamental step in elucidating the mechanisms that give rise to disease and will provide insights into methods for effective treatment. Systemic lupus erythematosus (SLE) is one of the most prevalent autoimmune diseases, affecting two million people in the USA. This disease has a 9:1female-to-male bias; symptoms usually arise during women’s child-bearing years [1,2]. Lupus is most common in minority populations, such as African Americans, Latinos and Native Americans. Lupus disease is associated with a wide range of symptoms. In its mildest form, this disease causes general fatigue, fevers and skin rashes. In its most severe form, lupus causes a lethal inflammatory disease that leads to kidney, heart and lung failure. A hallmark of this disease is the presence of anti-nuclear antibodies (ANA) in the serum, which is an indication of B-cell reactivity against common self antigens. Our laboratory is conducting research that aims to understand genetic and environmental causes of lupus disease. We are investigating animal models of lupus disease in order to identify novel susceptibility factors and to discover mechanisms underlying the onset of systemic autoimmune disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Castro J, Balada E, Ordi-Ros J et al (2008) The complex immunogenetic basis of systemic lupus erythematosus, Autoimmun Rev 7:345–351
Jonsen A, Bengtsson A A, Nived O et al (2007) Gene-environment interactions in the aetiology of systemic lupus erythematosus, Autoimmunity 40:613–617
Ravetch J V & Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19 275– 290
Bolland S & Ravetch J V (2000) Spontaneous autoimmune disease in FcgRII deficient mice results from strain-specific epistasis, Immunity 13:277–285
Bolland S, Yim Y S, Tus K et al (2002) Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice, J Exp Med 195:1167–1174
Tarasenko T, Dean J A, Bolland S (2007) FcgammaRIIB as a modulator of autoimmune disease susceptibility, Autoimmunity 40:409–417
Mackay M, Stanevsky A, Wang T et al (2006) Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE, J Exp Med 203:2157–2164
Tarasenko T, Kole H K, Bolland S (2008) A lupus-suppressor BALB/c locus restricts IgG2 autoantibodies without altering intrinsic B cell-tolerance mechanisms, J. Immunol 180:3807–3814
Chen C, Nagy Z, Prak E L et al (1995) Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing, Immunity 3:747–755
Chen C, Prak E L, Weigert M (1997) Editing disease-associated autoantibodies, Immunity 6:97–105
Li,H, Jiang Y, Prak E L et al (2001) Editors and editing of anti-DNA receptors, Immunity 15:947–957
Fukuyama H, Nimmerjahn F, Ravetch J V (2005) The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells, Nat. Immunol 6:99–106
Murphy E D & Roths J B (1979) A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation, Arthritis Rheum 22:1188–1194
Izui S, Iwamoto M, Fossati L et al (1995) The Yaa gene model of systemic lupus erythematosus, Immunol Rev 144: 137–156
Amano H, Amano E, Moll T et al (2003) The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells, J Immuno 170:2293–2301
Amano H, Amano E, Santiago-Raber M L et al (2005) Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus, Arthritis Rheum 52:2790–2798
Anolik J H, Barnard J, Owen T et al (2007) Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy, Arthritis Rheum 56: 3044–3056
Pisitkun P, Deane J A, Difilippantonio M J et al (2006) Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication, Science 312:1669–1672
Diebold S S, Kaisho T, Hemmi H et al (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA, Science 303:1529–1531
Lund J M, Alexopoulou L, Sato A et al (2004) Recognition of single-stranded RNA viruses by Toll-like receptor 7, Proc Natl Acad Sci USA 101:5598–5603
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors, Annu Rev Immunol 21:335–376
Leadbetter E A, Rifkin I R, Hohlbaum A M et al (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors, Nature 416:603–607
Marshak-Rothstein A & Rifkin I R (2007) Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease, Annu Rev Immunol 25:419–441
Deane J A, Pisitkun P, Barrett R S et al (2007) Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation, Immunity 27:801– 810
Fairhurst A M, Hwang S H, Wang A et al (2008) Yaa autoimmune phenotypes are conferred by overexpression of TLR7, Eur J Immunol 38:1971–1978
Viglianti G A, Lau C M, Hanley T M et al (2003) Activation of autoreactive B cells by CpG dsDNA, Immunity 19:837–847
Chaturvedi A, Dorward D, Pierce S K (2008) The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens, Immunity 28:799–809
Lau C M, Broughton C, Tabor A S et al (2005) RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement, J Exp Med 202:1171–1177
Cella M, Jarrossay D, Facchetti F et al (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon, Nat Med 5:919–923
Colonna M, Krug A, Cella M (2002) Interferon-producing cells: on the front line in immune responses against pathogens, Curr Opin Immunol 14:373–379
Means T K, Latz E, Hayashi F et al (2005) Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9, J Clin Invest 115:407–417
Lee H K, Lund J M, Ramanathan B et al. (2007) Autophagy-dependent viral recognition by plasmacytoid dendritic cells, Science 315:1398–1401
Ono M, Bolland S, Tempst P et al (1996), Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB, Nature 383:263–266
Rohrschneider L R, Fuller J F, Wolf I et al (2000) Structure, function, and biology of SHIP proteins, Genes Dev 14:505–520
Bolland S, Pearse R N, Kurosaki T et al (1998) SHIP modulates immune receptor responses by regulating membrane association of Btk, Immunity 8: 509–516
Ono M, Okada H, Bolland S et al (1997), Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling, Cell 90:293–301
Kalesnikoff J, Sly L M, Hughes M R et al (2003), The role of SHIP in cytokine-induced signaling, Rev. Physiol Biochem Pharmacol 149:87–103
Helgason C D, Damen J E, Rosten P et al (1998) Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span Genes Dev 12:1610–1620
Aman M J, Lamkin T D, Okada H et al (1998) The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells, J Biol Chem 273:33922–33928
Liu Q, Sasaki T, Kozieradzki I et al (1999) SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival, Genes Dev., 13, 786–791.
Tarasenko T, Kole H K, Chi A W et al (2007) T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc Natl Acad Sci USA 104:11382–11387
Aranami T & Yamamura T (2008) Th17 Cells and autoimmune encephalomyelitis (EAE/MS), Allergol Int 57:115–120
Furuzawa-Carballed, J, Vargas-Rojas M I, Cabral A R (2007) Autoimmune inflammation from the Th17 perspective, Autoimmun Rev 6:169–175
Adelman M K & Marchalonis J J (2002) Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses, Clin Immunol 102:107–116
Hill N J, King C, &Flodstrom-Tullberg M (2008) Recent acquisitions on the genetic basis of autoimmune disease, Front Biosci 13:4838–4851
Zandman-Goddard G & Shoenfeld Y (2005) Infections and SLE. Autoimmunity 38:473–485
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Crampton, S.P., Bolland, S. (2010). Mind Your Xs and Ys: Genetics of the Autoimmune Disease Systemic Lupus Erythematosus. In: Georgiev, V. (eds) National Institute of Allergy and Infectious Diseases, NIH. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-512-5_37
Download citation
DOI: https://doi.org/10.1007/978-1-60761-512-5_37
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-511-8
Online ISBN: 978-1-60761-512-5
eBook Packages: MedicineMedicine (R0)